The Therapeutic Advances In Hematology is reputed journal publishes research related to Medicine. The ISSN of the journal is 2040-6215.
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Therapeutic Advances in Hematology |
|---|---|
| Publisher | SAGE Publications |
| Publication Country | 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP |
| ISSN | 2040-6215 |
| Publication Area | Hematology |
| Publication Language | English |
| Review Process | Anonymous peer review |
| Scopus Indexed | Yes |
The Impact Factor of Therapeutic Advances In Hematology in 2026 is 3.4.
The Therapeutic Advances In Hematology is ranked in Q2.
The Therapeutic Advances In Hematology is indexed in: DOAJ, Scopus, Web of Science, PubMed, Embase, UGC CARE Group 2.
There is a fee to publish in the Therapeutic Advances In Hematology. The publication fee is 2300 USD.
The journal also offers a fee waiver policy.
The Therapeutic Advances In Hematology takes an average of 7 weeks to publish research papers.
The official website of the journal is https://journals.sagepub.com/home/tah.
Please visit only official website of the journal to submit research papers.